237 / 490
235
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
ELECTRONIC POSTERS
> Normal tissue exposure in SBRT: Retrospective QA on a prospective
cohort - what have we learned?
S. Adebahr (Germany), J. Hinck, R. Wiehle, T. Schimek-Jasch, E. Gkika,
A.L. Grosu, U. Nestle
EP-1240
> Relationship of dosimetric findings and toxicity following SABR for lung
cancer
K. Johnson (UK), A. Morenc, T. Sridhar, L. Aznar-Garcia
EP-1241
> stereotactic body radiation therapy for early stage NSCLC: clinical
outcomes
A. Iurato (Italy), A. Carnevale, E. Ippolito, M. Fiore, C. Greco, L.E. Trodella,
A. Di Donato, S. Ramella, R.M. D’Angelillo, L. Trodella
EP-1242
> A multicentre clinical trial using 3DCRT to reduce toxicity of palliative
radiation for lung cancer
R. McDermott (Ireland)
EP-1243
> Radiotherapy for loco-regional recurrence of non-small-cell lung cancer
after complete resection
K. Terashima (Japan), M. Inamori, A. Matsunobu, H. Hirata,
K. Sakamoato, K. Okabayashi, A. Furuya, M. Hirakawa
EP-1244
> BED <100Gy and ITV ≥20cc predict local relapse after stereotactic
radiation therapy for lung cancer
A. Suissa (France), A. Levy, F. Belkhir, N. Grellier-Adedjouma, P. Xu,
F. Martinetti, C. Le Péchoux
EP-1245
> Is there a different dose-effect relation between the tumour and involved
lymph nodes in NSCLC?
L. Van den Bosch (Belgium), G. Defraene, S. Peeters, C. Dooms,
W. De Wever, C. Deroose, D. De Ruysscher
EP-1246
> Is CC Chemokine Ligand 18 a biomarker for the prediction of radiation
induced lung disease?
E. Gkika (Germany), S. Adebahr, T. Schimek-Jasch, A. Brenner,
T. Brunner, A. Prasse, G. Ziessel, A.L. Grosu, U. Nestle
EP-1247
> Lung re-irradiation with stereotactic body radiation therapy (SBRT)
P. Bonome (Italy), C. Scaringi, M. Valeriani, V. De Sanctis, G. Minniti,
M.F. Osti
EP-1248